Data Management
OCT works with web-based data and provides full-service support through all phases of clinical development
We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
OCT works with web-based data and provides full-service support through all phases of clinical development
Our team is dedicated to delivering high quality and accurate data within the desired timelines and tailored to the sponsors’ specific needs. Results of both internal and external audits of our EDС and Data Management process have verified our compliance with all regulations of data-feeding outlined by respective Ministries of Health, FDA and EMA and local regulating bodies in the countries where we run our operations.
Learn the advice, tips and tricks from the experts to power your data driven decisions.
We are pleased with OCT Clinical’s ability to meet our data management needs within our timeline.
The results OCT Clinical has been demonstrating as the principal CRO for the project were outstanding.
The OCT Clinical team met our goals under very difficult conditions. The achievement is quite impressive, considering the challenging circumstances imposed by the global pandemic.
Anastasiia Zaitseva
Head of Data Management
Clinical Data Management is critical in clinical research. The goal of data management is to provide statistically sound data with the minimum number of errors and missing values. To achieve that we use various software solutions, which, combined with best practices, help improve data quality.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
